Protein Laboratories Rehovot

Company Overview

Snapshot

Founded in August 2003 by Prof. Arieh Gertler, Protein Laboratories Rehovot operates with 1–10 employees. The company specializes in the production of biologically active recombinant proteins. A key milestone for the company was the development of technology for the production of biologically active recombinant protein in E. coli in August 2003.

Business overview

Protein Laboratories Rehovot (PLR) is a Health Tech & Life Sciences company focused on the production of biologically active recombinant proteins, primarily cytokines and their soluble receptors, utilizing E. coli. The company manages the entire process from optimizing sequences and over-expressing proteins as insoluble forms to purifying inclusion bodies and refolding them into biologically active proteins. PLR serves the pharmaceuticals sector, providing highly purified proteins for research and development, particularly in areas like genetic disorders.

Company Intelligence Q&A

What is Protein Laboratories Rehovot's primary focus?

Protein Laboratories Rehovot specializes in the production of biologically active recombinant proteins, including various cytokines and their soluble receptors, primarily using E. coli.

When was Protein Laboratories Rehovot founded?

Protein Laboratories Rehovot was founded in August 2003.

Who are the founders of Protein Laboratories Rehovot?

Protein Laboratories Rehovot was founded by Prof. Arieh Gertler.

What is the core technology developed by Protein Laboratories Rehovot?

In August 2003, Protein Laboratories Rehovot developed technology for the production of biologically active recombinant protein in E. coli.

What markets does Protein Laboratories Rehovot serve?

Protein Laboratories Rehovot operates in the global market, with a focus on Israel, serving the pharmaceuticals sector.